Clinically reviewed by the BioDental and BioHealth teams at ROZE BioHealth and BioDental Clinics, Dubai.
The most consequential health conversations of the next decade will be about ageing brains. Alzheimer’s disease already affects more than 55 million people worldwide, and that number is rising fast. Most of the public conversation focuses on the same handful of familiar levers: diet, exercise, sleep, cardiovascular health, and family history. All important. All being talked about.
What almost nobody is talking about is that two of the most compelling emerging biological factors linked to Alzheimer’s risk are sitting inside your mouth right now. Not the gums in a general sense. Not “bad hygiene.” Two specific, biologically distinct things, both documented in peer-reviewed neuroscience and biological dentistry literature, and both almost invisible in mainstream health conversations.
At ROZE BioHealth and BioDental Clinics in Dubai, this is exactly the territory biological dentistry is built to address. This article explains what those two things are, what the science actually shows, why the conversation is finally shifting, and what you can practically do about it.
The Mouth-Brain Conversation Most People Have Half-Heard
Before the two lesser-known factors, a brief map of what people usually know:
- Mercury from old amalgam fillings can cross the blood-brain barrier.
- Chronic gum disease drives systemic inflammation.
- Poor sleep and mouth breathing affect cognitive health.
- The oral microbiome influences the gut, which influences the brain.
All of this is real and well documented. But it stops short of the two specific findings that biological dentistry has been paying attention to for years, and that mainstream medicine is only now catching up to.
The First Thing: A Specific Gum Bacterium (and Its Toxic Proteins) Found in Alzheimer’s Brains
The first factor is a single species of bacteria called Porphyromonas gingivalis, and a family of enzymes it produces called gingipains. Almost nobody outside biological dentistry, periodontology, and Alzheimer’s research has heard of either. They are, however, one of the most consequential findings in recent Alzheimer’s science.
What P. gingivalis is
Porphyromonas gingivalis is what microbiologists call a “keystone pathogen” in chronic gum disease. It sits at the top of the microbial pyramid that drives periodontitis, the deeper, more destructive form of gum disease. Almost every adult with significant gum inflammation has some level of it.
What gingipains are
Gingipains are the toxic enzymes P. gingivalis uses to break down human tissue. There are three main types (Kgp, RgpA, and RgpB). They are the bacterium’s weapon system. In the mouth, they degrade gum tissue, disrupt immune signalling, and enable the bacterium to establish chronic infection.
The finding that changed the conversation
In January 2019, a landmark paper by Dominy and colleagues, published in Science Advances, made a finding that has quietly reshaped Alzheimer’s research. In postmortem brain samples from Alzheimer’s patients, the team identified:
- P. gingivalis DNA present in the brain, particularly in the hippocampus, the memory centre
- Gingipains in approximately 96% of the 54 Alzheimer’s brain samples examined
- Gingipain levels correlating with tau and ubiquitin pathology, two hallmark markers of Alzheimer’s neurodegeneration
- Gingipains localised near neurons, associated with tau tangles and intracellular amyloid beta
The team then confirmed the mechanism in mice. Oral P. gingivalis infection led to brain colonisation and increased production of amyloid beta 1-42, the peptide that forms amyloid plaques. Later work confirmed that P. gingivalis can actually invade neurons and continue producing gingipains inside them.
The final step was pharmaceutical. Small-molecule inhibitors of gingipains reduced the bacterial load in the brain, blocked amyloid production, reduced neuroinflammation, and rescued neurons in the hippocampus. The research group behind these findings has since progressed gingipain inhibitors into Alzheimer’s clinical trials.
Why almost nobody has heard of it
Because this story lives at the intersection of periodontology, microbiology, and neuroscience. Most patients only hear a version of it if their dentist happens to practice biological dentistry, or if they read the neuroscience press. It has not filtered into mainstream conversation yet, which is exactly why it is worth writing about.
What it means practically
Chronic gum disease is no longer just a gum problem. In a subset of patients, chronic P. gingivalis infection appears to be part of the biological chain that ends in Alzheimer’s disease. Treating and preventing periodontitis at a biological level is, from this vantage point, a genuinely neurological act.
The Second Thing: Silent, Painless Dental Infections at the Root Tips of Teeth
The second factor is even less discussed. It is not a bacterium. It is a category of dental problem: asymptomatic apical periodontitis, or chronic silent infection at the root tips of teeth, most commonly in and around endodontically treated (root canal) teeth.
The reason nobody talks about it is because it does not hurt. And in modern healthcare, what does not hurt tends not to get treated.
What asymptomatic apical periodontitis actually is
At the tip of every tooth root sits a small opening that allows the nerve and blood supply to enter and exit the tooth. If that space becomes chronically infected, whether after a deep cavity, a failed root canal, incomplete root canal treatment, a small crack, or gradual reinfection over years, it forms a persistent inflammatory lesion in the surrounding bone. This is apical periodontitis.
In its acute form, it is painful. In its chronic form, it is often completely painless. The infection continues quietly, releasing bacteria, bacterial byproducts, and inflammatory mediators into the surrounding bone, the lymphatic system, and the bloodstream, day after day, for years or decades.
How common it is
The number that should catch every reader’s attention: approximately 52% of adults globally have at least one tooth affected by apical periodontitis, according to a 2021 systematic review and meta-analysis. That is not a rare condition. That is more than half the adult population walking around with a silent inflammatory source in their jaw that they do not know about.
What the research shows about its systemic impact
A 2023 prospective study by Sathyanarayanan and colleagues, published in Cureus, evaluated 25 patients with asymptomatic apical periodontitis and no known systemic diseases. Blood samples showed measurable systemic inflammatory changes driven by the silent lesion, changes that improved after root canal therapy. This is the biological signature of an infection that most patients do not know exists.
A broader 2024 narrative review on the “two-way communication” between apical periodontitis and systemic disorders described the same phenomenon: chronic asymptomatic apical periodontitis triggers systemic immune responses through cytokines and pathogens entering the bloodstream, and is now considered a systemic issue rather than a purely dental one.
The cognitive angle
The cognitive science on chronic oral inflammation is where the picture gets particularly sobering. A six-month observational cohort study of 60 community-dwelling adults with mild to moderate Alzheimer’s disease, published in PLOS ONE (Ide and colleagues), found that the presence of periodontitis at baseline was associated with a six-fold increase in the rate of cognitive decline over the follow-up period. The relationship was linked to a heightened systemic pro-inflammatory state.
That is not a small effect. It is one of the largest modifiable-risk-factor findings in the Alzheimer’s literature, and it points squarely at chronic oral inflammation, whether from visible gum disease or from silent apical periodontitis, as a driver of how fast the brain declines once decline begins.
Why almost nobody has heard of it
Because the standard dental narrative is: “If it does not hurt, and there is nothing visible on the X-ray you can easily interpret, you are fine.” Silent apical periodontitis often does not appear clearly on a standard bitewing X-ray. It is best identified with three-dimensional cone-beam CT imaging (CBCT), which is not routinely used unless a biological or endodontic evaluation is done.
Which means that for the majority of adults, this problem is quite literally invisible in the way healthcare currently looks.
What These Two Things Have in Common
Both P. gingivalis infection and chronic apical periodontitis share a single quiet mechanism: persistent, low-grade oral inflammation feeding directly into the systemic circulation, immune system, and eventually the brain. In a biological dentistry framework, this is one of the most important upstream drivers of ageing biology that most patients have never had assessed.
They are not the same problem. Gum disease sits above the tooth in the soft tissue. Apical periodontitis sits at the root tip inside the bone. But their downstream effect (a chronic pro-inflammatory state) is essentially the same. And their relevance to brain health is essentially the same.
Conventional vs Biological Framing: A Clear Comparison
| Aspect | Conventional Dental View | Biological Dental View at ROZE |
|---|---|---|
| Gum disease | Local issue, treated when visible | Systemic inflammatory driver with brain implications |
| Root-treated teeth | Considered “sealed” once treated | Actively monitored for silent chronic infection |
| Asymptomatic infections | Not routinely investigated | Assessed as a serious systemic risk |
| Imaging | 2D bitewings and panoramic | CBCT where clinically indicated for silent lesions |
| Materials | Metal alloys, mercury tolerated | Metal-free, biocompatible only |
| Systemic connections | Rarely discussed | Central to planning |
| Prevention target | Cavities | Chronic inflammation, microbiome, silent infection |
The Bigger Biological Picture
The two factors do not exist in isolation. They fit inside a wider oral-brain framework:
- Chronic oral inflammation drives systemic inflammation (“inflammaging”), which is one of the mechanisms behind cognitive decline
- The blood-brain barrier is not absolute. Certain bacteria, bacterial toxins, and inflammatory mediators can cross it, particularly when the barrier is chronically inflamed
- The oral microbiome seeds the gut microbiome, influencing the gut-brain axis
- Sleep-disordered breathing, driven by oral and airway biology, quietly damages the brain through poor sleep quality and reduced oxygenation
- Heavy metal exposure from dental materials adds an additional layer of neurological burden
None of these are alarmist claims. All of them sit in peer-reviewed literature. What is different in biological dentistry is that all of them are on the table in a single clinical conversation.
What ROZE Does Differently
For patients concerned about the mouth-brain connection, the ROZE approach is designed around it. A typical patient pathway includes:
- Comprehensive biological dental assessment, including a proper evaluation of gum health, oral microbiome balance, and existing dental work
- CBCT imaging where clinically indicated, to identify silent apical periodontitis and hidden bone infections
- Biological gum treatment, including ozone therapy to gently disinfect the periodontal pockets and calm inflammation
- Regenerative endodontics or careful biological management of teeth with silent apical infection
- SMART amalgam removal for patients wanting to reduce lifelong heavy metal exposure, delivered under strict safety protocols
- Ceramic implants for patients seeking a fully metal-free implant option
- Integrated functional medicine input via Dr. Yslème Delhoum, Dr. Priyanka Sainani and Dr. Sindy Yambo to address the systemic inflammation, gut health, and longevity dimensions
- Biological physiotherapy with Sandra Serrano to support lymphatic drainage, vagus nerve regulation, and inflammation control
- Preventive nutrition and lifestyle strategies, including hydroxyapatite-based oral care and oral-microbiome-supportive habits
This is a lot of moving parts. That is the point. The mouth-brain conversation is not a single intervention. It is a coherent, ongoing biological strategy.
Why This Matters in Dubai
Dubai has one of the most health-literate, high-performing populations in the region, and one of the strongest interests in longevity anywhere in the world. That population is well positioned to benefit from a biological dental framework because the value compounds over decades. Every year without silent inflammation, every year without avoidable heavy metal exposure, every year with a healthier oral microbiome, is a year the brain is not being pushed uphill.
At ROZE, this is not framed as an alternative or fringe conversation. It is standard biological dentistry, delivered inside a fully integrated clinical model.
Risks and Considerations
Honest expectations matter:
- The P. gingivalis hypothesis is one hypothesis for Alzheimer’s disease, not the settled cause. It is supported by strong biological evidence, but Alzheimer’s is a multifactorial condition. Reducing P. gingivalis burden is protective and preventive; it is not a guarantee.
- Asymptomatic apical periodontitis is common but manageable. Identifying it early opens the door to biological, regenerative, or minimally invasive treatment.
- Not every root-treated tooth is silently infected. Careful clinical judgement, imaging, and honest patient conversation guide decisions.
- Biological dentistry is precautionary, not alarmist. The aim is to reduce avoidable lifelong risk, not to catastrophise.
- Biological dentistry works alongside conventional medical care, not instead of it. Any suspected cognitive changes should be assessed by a qualified medical practitioner.
Frequently Asked Questions
What is Porphyromonas gingivalis?
P. gingivalis is a bacterium considered the keystone pathogen in chronic gum disease (periodontitis). It has been identified in Alzheimer’s brain samples in landmark research, along with its toxic gingipain enzymes.
What are gingipains?
Gingipains are toxic enzymes produced by P. gingivalis. They break down human tissue, disrupt immune responses, and have been found in the brains of Alzheimer’s patients, associated with tau tangles and amyloid pathology.
Does having gum disease mean I will get Alzheimer’s?
No. Alzheimer’s is multifactorial, and P. gingivalis is one contributing factor among several. What the research does suggest is that reducing chronic oral inflammation is a legitimate part of a serious brain-health strategy.
What is asymptomatic apical periodontitis?
It is a silent, painless infection at the tip of a tooth root, most commonly in root-canal-treated teeth. It affects roughly half of the adult population globally and continuously feeds inflammation into the systemic circulation.
How do I know if I have a silent apical infection?
You often will not know from symptoms alone, because it does not hurt. Identification typically requires clinical examination combined with 3D cone-beam CT imaging (CBCT), which is not routinely performed unless a biological or endodontic assessment is done.
Can silent apical periodontitis be treated?
Yes. Depending on the case, treatment options include careful biological retreatment of an existing root canal, regenerative endodontics, minor surgical management, or in some cases extraction with a biocompatible replacement.
Does gum disease treatment reduce dementia risk?
The evidence supports a strong link between chronic oral inflammation and cognitive decline rate. Treating periodontitis reduces the inflammatory burden and appears to slow cognitive decline in patients with Alzheimer’s, based on published cohort research.
What about mercury fillings and the brain?
Mercury vapor from amalgam fillings can cross the blood-brain barrier, according to peer-reviewed toxicology reviews. Population-level causation with specific diseases like Alzheimer’s remains debated, but a precautionary, biological approach favours reducing avoidable lifelong exposure.
Is a biological dental assessment worth doing if I have no symptoms?
Yes, particularly if you have any of the following: root canal treated teeth, older amalgam fillings, chronic gum inflammation, family history of Alzheimer’s or dementia, or a personal commitment to longevity.
Where in Dubai can I get a biological dental assessment?
ROZE operates MOH-approved clinics in Jumeirah, DIFC, and The Greens, offering biological dentistry, functional medicine, longevity care, and integrative therapies within one clinical environment.
A Final Thought
Alzheimer’s disease is one of the most complex, multifactorial conditions in modern medicine. There is no single cause, and there will not be a single cure. But there are drivers, and some of them are quietly sitting inside mouths that have never been assessed for them.
The two factors this article has focused on, chronic P. gingivalis infection with its gingipain toxins, and silent asymptomatic apical periodontitis, are two of the most under-discussed but scientifically supported oral contributors to long-term brain risk. Almost nobody has heard of either. Both are addressable. Both are exactly the kind of upstream, biological, preventive work that ROZE was built to do.
If you would like to explore what a biological, brain-conscious assessment of your own mouth could look like, the ROZE BioHealth and BioDental team in Dubai would be glad to walk you through it, honestly and in detail. Because the most powerful things you can do for your future brain may already be sitting quietly in your mouth, waiting to be noticed.